SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-18-015759
Filing Date
2018-03-20
Accepted
2018-03-20 10:48:44
Documents
1
Period of Report
2018-03-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv488976_4a.html 4/A  
1 OWNERSHIP DOCUMENT tv488976_4a.xml 4/A 4074
  Complete submission text file 0001144204-18-015759.txt   5810
Mailing Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019
Business Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS, INC. 3 UNIVERSITY PLAZA DRIVE, SUITE 320 HACKENSACK NJ 07601
Business Address
Kern Ralph Dr. (Reporting) CIK: 0001699684 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36641 | Film No.: 18700987